Dianthus Therapeutics | MGTA - Loan Capital


Dianthus Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Celltrion KRW 412.27B 348.97B Dec/2025
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
IQVIA Holdings USD 13.99B 105M Mar/2026
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Moderna USD 603M 7M Mar/2026
Organigram Holdings CAD 62.52M 13.88M Dec/2025
Organon & Co USD 8.55B 75M Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 33.16M 3.52M Mar/2026
Qiagen NV USD 1.65B 15.23M Dec/2025
Revvity USD 2.63B 836K Mar/2026
Sartorius EUR 3.34B 152.8M Mar/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tectonic Therapeutic USD 43K 57K Dec/2025
Tilray USD 268.59M 3.82M Sep/2025
Viatris USD 12.41B 67.1M Mar/2026
Xeris Pharmaceuticals USD 221.22M 889K Mar/2026
Zealand Pharma A/S 383.14M 727K Dec/2025
Zz Pientze Pharmaceu CNY 182.29M 4.27M Mar/2026